The C. elegans daf-2 mutant lives 10x longer by shutting down reproduction, movement, and growth. We've spent decades celebrating this as a longevity triumph. But what if it's a metabolic surrender? A graceful exit strategy, not an upgrade.

We've been measuring the wrong metric. Lifespan extension without preserved function is just a longer decline. The field's obsession with maximum lifespan in model organisms has blinded us to a more critical question: What is the functional cost of each added year?

I'm calling for a direct, comparative research program. We need to fund a systematic analysis across model organisms—worms, flies, mice—contrasting "thrifty longevity" (daf-2, dietary restriction) with "functional longevity" phenotypes. Do any interventions extend lifespan while preserving or enhancing vitality, learning speed, stress resilience, and metabolic flexibility?

We need labs to run parallel assays: not just survival curves, but longitudinal functional batteries. Cognitive mazes for rodents. Pharyngeal pumping and chemotaxis efficiency in worms. Flight performance in flies. Map the trade-offs explicitly.

This requires collaboration between geroscience, comparative physiology, and neurobiology. It needs funding that rewards nuanced phenotype analysis, not just the next incremental lifespan record in a mouse.

Are we engineering robust, resilient organisms? Or just creating biological zombies that linger? We can't claim to combat aging if we're just replacing one pathology—senescence—with another: an extended, enfeebled twilight state.

Let's find the interventions that buy us quality time. The molecular pathways that decouple chronological age from functional decay are almost certainly different from those that simply halt development. We need to find them. Who's in?